Antimicrobial resistance or decreased susceptibiity (DS/R) to in Colombia

Colombia: Antimicrobial resistance or decreased susceptibiity (DS/R) to was 10.1 in 2022. ◆ Volatile

Latest (2022)
10.1
Change on year
up 6.3%
World rank
27th
of 54 countries
All-time high
45.4
in 2017
All-time low
0
in 2009
Years of data
7
2009–2022

Antimicrobial resistance or decreased susceptibiity (DS/R) to in Colombia, 2009–2022

010203040502009201520222009: 02015: 9.22016: 20.52017: 45.42018: 27.32020: 9.52022: 10.1

Source: World Health Organization, Global Health Observatory.

Analysis

In 2022, antimicrobial resistance or decreased susceptibiity (ds/r) to in Colombia stood at 10.1.

That represents a change of up 6.3% on the previous year and down 77.8% over five years.

Over the whole period, antimicrobial resistance or decreased susceptibiity (ds/r) to in Colombia peaked at 45.4 in 2017 and was at its lowest, 0, in 2009.

Colombia ranks 27th of 54 countries on this measure, in the middle of the range.

Antimicrobial resistance or decreased susceptibiity (DS/R) to in Colombia, year by year

Annual values for Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion) in Colombia, 2009 to 2022.
Year Value Change
2009 0
2015 9.18
2016 20.49 +123.2%
2017 45.4 +121.6%
2018 27.3 -39.9%
2020 9.5 -65.2%
2022 10.1 +6.3%

Colombia compared with similar countries

  • Colombia's 10.1 is above the median for upper middle income countries, which is 3.39, 3.0× the median. (13 countries reporting)
  • Colombia's 10.1 is below the median for Latin America & Caribbean, which is 13.1, 77% of the median. (5 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 0 0 0 1
2010s 25.59 9.18 45.4 4
2020s 9.8 9.5 10.1 2

Countries ranked near Colombia

  1. 25 France 12.3 compare
  2. 26 Slovenia 11.2 compare
  3. 28 Singapore 9.68 compare
  4. 29 United Kingdom of Great Britain and Northern Ireland 8.29 compare
  5. 30 Cambodia 8.2 compare

See the full ranking of 54 places →

More health data for Colombia

All data for Colombia →

Frequently asked questions

What is antimicrobial resistance or decreased susceptibiity (ds/r) to in Colombia?
Antimicrobial resistance or decreased susceptibiity (ds/r) to in Colombia was 10.1 in 2022, according to World Health Organization, Global Health Observatory.
What is the highest antimicrobial resistance or decreased susceptibiity (ds/r) to recorded in Colombia?
The highest recorded value was 45.4 in 2017.
What is the lowest antimicrobial resistance or decreased susceptibiity (ds/r) to recorded in Colombia?
The lowest recorded value was 0 in 2009.
How does Colombia rank for antimicrobial resistance or decreased susceptibiity (ds/r) to?
Colombia ranks 27th out of 54 countries with data for 2022.
Where does this Colombia data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 7 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Antimicrobial resistance or decreased susceptibiity (DS/R) to in Colombia. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 14 September 2026, from https://health.statizoid.com/stat/antimicrobial-resistance-or-decreased-susceptibiity-ds-r-to-antimicrobials-in-neisseria/colombia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/antimicrobial-resistance-or-decreased-susceptibiity-ds-r-to-antimicrobials-in-neisseria/colombia/">Antimicrobial resistance or decreased susceptibiity (DS/R) to in Colombia</a> — Statizoid

About this data

Indicator
Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
54 places, 491 data points, 2009–2022
Last refreshed